INTRODUCTION

46
Injury of the Achilles tendon is one of the most common tendon injuries that effects adolescent 47 and adult populations. [1] [2] [3] Achilles rupture and tendinopathy are often debilitating, resulting in 48 limited mobility, impaired joint function, and elevated risk of long-term disability and pain if left 49 untreated. 1, 4, 5 Unfortunately, tendon injuries are difficult to treat. 6, 7 Following surgical repair, the 50 risk of re-rupture of the Achilles tendon is greater than 15% and is elevated in patients under the 51 age of 30. [8] [9] [10] Similarly, non-operative therapies such as non-steroidal anti-inflammatory drugs, 52 platelet-rich plasm injections, and physical therapy regimens often leave patients with persisting 53 symptoms, reduced function, and high re-rupture rates. 11, 12 Failure of the Achilles tendon to 54 adequately heal often results from poor cell-mediated reintegration, remodeling, and regeneration 55 during the healing process. 13 Therefore, developing and improving rehabilitative tools that can 56 regulate cell behavior during tendon healing are needed to accelerate tendon reintegration 57 following injury and reduce the risk of re-rupture following repair. 58 Photobiomodulation (PBM) therapy is a clinically-available tool for non-invasive treatment of 59 musculoskeletal injuries. PBM therapy can reduce rehabilitation time and improve treatment 60 outcomes when implemented in physical therapy and outpatient clinics. [14] [15] [16] [17] [18] [19] PBM therapy is the 61 application of near-infrared light to increase cellular metabolism, including ATP 20 and collagen 62 production 21, 22 . PBM use in muscle can activate mitochondria, 23-25 yet it is unclear if the cellular 63 mechanism of PBM is the same during tendon maturation and healing. Increased mitochondrial 64 signaling can influence many downstream targets that control metabolic activity as well as 65 apoptosis, cell proliferation, and collagen synthesis. 26 In addition, tissue remodeling and pain may 66 be regulated by the metabolic activity of tissues. 27 While promising results have been shown for 67 PBM treatment of adult tendon injuries in the clinic, 19 with small animal models, [28] [29] [30] [31] [32] [33] and in tandem 68 with other therapies, 19,34-36 the effect of PBM therapy on the maturation of tendon has not yet been 69 explored. This is important, because PBM therapy of adolescent tendon injuries may influence 70 the metabolic and remodeling processes of tendon during growth and therefore influence the long-71 4 term health of the tendon. Additionally, while PBM therapy is used to reduce pain and increase 72 return-to function for many patients with tendinopathy 16 and animal models of tendinopathy 28-33 , 73 little work has systematically investigated the therapeutic potential and functional outcomes of 74 PBM therapy on adult tendon healing. 37 Here, we investigated how PBM therapy modulates 75 mitochondrial metabolism in tendon and determined if and how PBM therapy can regulate the 76 organization, structure, and function of tendon during maturation and healing.
77
The purpose of this study was to investigate how PBM therapy affects the maturation of 78 tendon in vivo, as well as how PBM therapy modulates the structural and biomechanical 79 characteristics of the healing tendon. Specifically, we 1) assessed the effect of low-, high-, and 80 no-irradiance PBM therapy during tendon maturation and 2) evaluated the efficacy of high versus 81 no irradiance of PBM therapy during adult tendon healing. Using a paired study design ( Figure   82 1), we hypothesized that PBM therapy at low or high power would: acutely increase gene 83 expression related to mitochondria metabolism during tendon maturation and healing, not 84 damage the structural and mechanical properties of the maturing tendon, and improve the 85 structural and mechanical properties of the healing tendon. weighed during the dosing periods for the maturation study to make sure that repetitive anesthesia 116 6 or PBM therapy did not affect their growth (Supplemental Figure 1 ). Prior to PBM dosing, the hair 117 above the Achilles tendon and calf muscles was removed as needed using a topical cream 118 because hair absorbs a significant amount of light (Supplemental Figure 5 ). 38 Mice were then 119 placed in the prone position on a custom-made jig that holds the light probe perpendicular and 120 juxtaposed to the dorsal Achilles tendon in a hands-free manner to reduce variability between 121 doses (Thor Labs, Newton, NJ). Briefly, the dorsal foot was taped down in plantar flexion to keep 122 the Achilles tendon stable during dosing, then the light probe was lowered perpendicular to and 123 directly on top of the dorsal side of the Achilles tendon. The PBM dose was applied, the 124 contralateral limb was manipulated in the same manner but without PBM dosing, and then mice 125 were monitored until awake and alert.
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To determine the maturation-dependent effect of PBM irradiance on Achilles tendon structure 127 and function, unilateral Achilles tendons of 2-week old mice (N = 37 total) were dosed with low 128 irradiance (n=13, 7 females and 6 males) or high irradiance (n=8, 4 females and 4 males; 129 functional outcomes only) daily for 4-weeks ( Figure 1A 
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To determine the healing-dependent effect of PBM on Achilles tendons, adult mice (N = 17 135 total) that underwent bilateral Achilles tenotomy were dosed unilaterally with high irradiance daily 136 for either 7-weeks (structure/function assays; Figure 1B , n=13, 6 females and 7 males) or for 3 137 days and then sacrificed 4-hours after the third dose (differential gene expression; n=4 females; 138 Figure 1B ). Mice were euthanized with carbon dioxide asphyxiation and thoracotomy. 
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Data are presented as mean ± standard deviation (p<0.05).
248
Acute PBM Marginally Alters Mitochondrial Gene Expression
249
During both maturation and healing, several genes related to mitochondrial signaling were 250 differentially expressed following PBM treatment (Table 1) 293 14 to systematically investigate the role of PBM therapy on tendon structure, function, and 294 mitochondrial activity. In the present study, we did not find an overwhelming effect of PBM 295 therapy, with the parameters and times that we used, on tendon-specific mitochondrial 296 metabolism during growth or following injury. These findings may suggest that tendon-specific 297 mitochondria are not sufficiently influenced by PBM therapy. Alternatively, it is possible that the 298 parameters we used did not alter mitochondria metabolism. It is possible that other parameters 299 and altered dosing of PBM therapy may lead to altered mitochondrial-related gene expression. 40 300 At the parameters and time points that we assessed, we did identify marginal, statistically 301 significant differences in expression of several mitochondria-related genes induced by PBM 302 therapy during tendon maturation and healing (Table 1) . 41 The majority of differentially-expressed 303 genes that were regulated by PBM therapy were calcium-dependent small molecule transporters 304 that shuttle molecules into mitochondria through the inner membrane, which suggests that 305 calcium signaling may be affected by PBM therapy. 42, 43 306 During maturation, the sex-dependent effects of PBM therapy (i.e., differential gene 307 expression in males compared to females) are important to consider when establishing the 308 mechanism of action of PBM therapy or other treatment modalities that target mitochondria. Both 309 low and high irradiance PBM therapy regulated Slc25a23 and Slc25a24, and these genes may 310 be targets of PBM therapy in this scenario of tendon maturation. 42, 43 The differences we found 311 between irradiance groups (low versus high) suggest that the irradiance used may alter the 312 mechanism of action of PBM therapy. For example, we found that low irradiance led to 313 upregulated Slc25a23 and Slc25a24 and downregulated Bbc3, whereas high irradiance led to 314 downregulated Ucp2, Slc25a23, and Slc25a13 and upregulated Slc25a24. Although we identified 315 similar genes that were differentially expressed due to low and high irradiance PBM therapy, these 316 changes did not lead to changes in the structure or mechanical properties of the tendon during 317 maturation, as hypothesized. 
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